Treatment of fungal infections in patients infected with the human immunodeficiency virus
Sugar, A.M.
PharmacoTherapy 10(6): 154s-158s
1990
ISSN/ISBN: 0277-0008 PMID: 2075115 Document Number: 355695
Mycoses due to a variety of organisms have been implicated as opportunistic pathogens in patients infected with HIV. These infections are a cause of significant morbidity and mortality, and most often require life-long antifungal medication to suppress reactivation of the fungal process. With the advent of newer antifungal drugs, such as fluconazole and itraconazole, options are available so that appropriate nontoxic, long-term therapy can be administered. As the number of HIV-infected people increases and their longevity is extended, fungi will continue to pose challenging problems in diagnosis and therapy.
Document emailed within 1 workday
Related Documents
Shailaja, V.V.; Pai, L.A.; Mathur, D.R.; Lakshmi, V. 2004: Prevalence of bacterial and fungal agents causing lower respiratory tract infections in patients with human immunodeficiency virus infection Indian Journal of Medical Microbiology 22(1): 28-33Villanueva, J.L.; Prada, J.L.; Kindelán, J.M.; Torre-Cisneros, J. 1994: CD4+ lymphocytes and opportunistic infections and neoplasms in patients infected with the human immunodeficiency virus Medicina Clinica 103(19): 758-759
Rebbani, K.; Ouladlahsen, A.; Bensghir, A.; Akil, A.; Lamdini, H.; Issouf, H.; Brahim, I.; Kitab, B.; Fakhir, F.Z.; Wakrim, L.; Marhoum El Filali, K.; Himmich, H.; Ezzikouri, S.; Benjelloun, S. 2013: Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 19(10): E454-E457
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Wuhib, T.; Silva, T.M.; Newman, R.D.; Garcia, L.S.; Pereira, M.L.; Chaves, C.S.; Wahlquist, S.P.; Bryan, R.T.; Guerrant, R.L.; Sousa, A.d.Q. 1994: Cryptosporidial and microsporidial infections in human immunodeficiency virus-infected patients in northeastern Brazil Journal of Infectious Diseases 170(2): 494-497
Chayakulkeeree, M.; Naksanguan, T. 2015: Epidemiology and clinical characteristic of mycobacterial infections in human immunodeficiency virus-infected patients in Siriraj Hospital Journal of the Medical Association of Thailand 98(3): 238-244
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Begovac, J.; Romih, V. 2009: Treatment of chronic hepatitis C in human immunodeficiency virus infected patients Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(5): 423-429
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Kaplan, J.E.; Hu, D.J.; Holmes, K.K.; Jaffe, H.W.; Masur, H.; De Cock, K.M. 1996: Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world American Journal of Tropical Medicine and Hygiene 55(1): 1-11
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Papas, R.K.; Sidle, J.E.; Gakinya, B.N.; Baliddawa, J.B.; Martino, S.; Mwaniki, M.M.; Songole, R.; Omolo, O.E.; Kamanda, A.M.; Ayuku, D.O.; Ojwang, C.; Owino-Ong'or, W.D.; Harrington, M.; Bryant, K.J.; Carroll, K.M.; Justice, A.C.; Hogan, J.W.; Maisto, S.A. 2011: Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya Addiction 106(12): 2156-2166
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062